Editorials

Screening could seriously damage your health

The costs and benefits of screening programmes are generating more than their usual share of interest. Last week the NHS Executive's new national screening committee held a press conference at the Royal College of Surgeons and declared that the costs of prostate cancer screening–in terms of impotence, incontinence, postoperative mortality, and psychological disturbance–outweighed any possible benefits. This statement was made possible because of two systematic reviews commissioned by the Health Technology Assessment programme.^{1 2} Many more systematic reviews of screening programmes are due to be reported soon, so the debate on screening will continue to run.

The decision about prostate cancer screening was relatively easy because there is no reliable evidence that early treatment improves outcome and the operative morbidity is unacceptable. But for some programmes due to be reported on soon the decisions may be more difficult; the benefits of a small increase in life expectancy or reduction in disability . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

Helen C Eborall, Simon J Griffin, A Toby Prevost, Ann-Louise Kinmonth, David P French, and Stephen Sutton
BMJ 2007 335: 486. [Abstract] [Full Text] [PDF]

Informed participation in screening is essential

A E Raffle
BMJ 1997 314: 1762. [Extract] [Full Text]

This article has been cited by other articles:

• Llewellyn, C., Pollard, A., Smith, H., Fisher, M., on behalf of the Home Sampling Kit Study Group, (2009). Are home sampling kits for sexually transmitted infections acceptable among men who have sex with men?. J Health Serv Res Policy 14: 35-43 [Abstract] [Full text]  
• Marcovitch, H. (2008). Screening for abdominal aortic aneurysms. Clin Risk 14: 207-207 [Full text]  
• Lauritzen, T., Ager Jensen, M. S., Thomsen, J. L., Christensen, B., Engberg, M. (2008). Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs: An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scand J Public Health 36: 650-661 [Abstract]  
• Eborall, H. C, Griffin, S. J, Prevost, A T., Kinmonth, A.-L., French, D. P, Sutton, S. (2007). Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 335: 486-486 [Abstract] [Full text]  
• McNaughton-Collins, M., Walker-Corkery, E., Barry, M. J. (2004). Health-Related Quality of Life, Satisfaction, and Economic Outcome Measures in Studies of Prostate Cancer Screening and Treatment, 1990-2000. J Natl Cancer Inst Monogr 2004: 78-101 [Abstract] [Full text]  
• Murthy, G. D., Byron, D. P., Pasquale, D. (2004). Underutilization of Digital Rectal Examination When Screening for Prostate Cancer. Arch Intern Med 164: 313-316 [Abstract] [Full text]  
• Edwards, A., Unigwe, S., Elwyn, G., Hood, K. (2003). Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 327: 703-709 [Abstract] [Full text]  
• Lederle, F. A. (2003). Ultrasonographic Screening for Abdominal Aortic Aneurysms. ANN INTERN MED 139: 516-522 [Abstract] [Full text]  
• Miles, A., Wardle, J., McCaffery, K., Williamson, S., Atkin, W. (2003). The Effects of Colorectal Cancer Screening on Health Attitudes and Practices. Cancer Epidemiol. Biomarkers Prev. 12: 651-655 [Full text]  
• Morgan, S., Hurley, J., Miller, F., Giacomini, M. (2003). Predictive genetic tests and health system costs. CMAJ 168: 989-991 [Full text]  
• Spijkerman, A. M.W., Adriaanse, M. C., Dekker, J. M., Nijpels, G., Stehouwer, C. D.A., Bouter, L. M., Heine, R. J. (2002). Diabetic Patients Detected by Population-Based Stepwise Screening Already Have a Diabetic Cardiovascular Risk Profile. Diabetes Care 25: 1784-1789 [Abstract] [Full text]  
• Eskild, A., Magnus, P. (2001). Commentary: Little evidence of effective prenatal treatment against congenital toxoplasmosis--the implications for testing in pregnancy. Int J Epidemiol 30: 1314-1315 [Full text]  
• Nordenstrom, A., Wedell, A., Hagenfeldt, L., Marcus, C., Larsson, A. (2001). Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants. Pediatrics 108: e68-68 [Abstract] [Full text]  
• Committee on Bioethics, (2001). Ethical Issues With Genetic Testing in Pediatrics. Pediatrics 107: 1451-1455 [Abstract] [Full text]  
• , T. E. C. W. G. (2000). Screening before and during the use of oral contraceptives and hormone replacement therapy. Hum Reprod 15: 485-492 [Abstract] [Full text]  
• Douglas, F. S, O'Dair, L. C, Robinson, M., Evans, D G. R, Lynch, S. A (1999). The accuracy of diagnoses as reported in families with cancer: a retrospective study. J. Med. Genet. 36: 309-312 [Abstract] [Full text]  
• Donovan, J. L, Frankel, S. J, Faulkner, A., Selley, S., Gillatt, D., Hamdy, F. C (1999). Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom. BMJ 318: 299-300 [Full text]  
• The CDC Diabetes Cost-Effectiveness Study Group, (1998). The Cost-effectiveness of Screening for Type 2 Diabetes. JAMA 280: 1757-1763 [Abstract] [Full text]  
• Wells, J., Ong, G. J, Bastian, H. (1998). Mammography and the politics of randomised controlled trials • Commentary: The public has a role to play in translating evidence into practice • Commentary: Why are researchers surprised when there is not a smooth transition from research into practice?. BMJ 317: 1224-1230 [Full text]  
• Towler, B., Irwig, L., Glasziou, P., Kewenter, J., Weller, D., Silagy, C. (1998). A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 317: 559-565 [Abstract] [Full text]  
• O'Connor, B. (1998). More collaboration is needed about benefits of new genetic screening tests. BMJ 317: 471a-471 [Full text]  
• Barlow, J., Stewart-Brown, S., Fletcher, J. (1998). Systematic review of the school entry medical examination. Arch. Dis. Child. 78: 301-311 [Abstract] [Full text]  
• SAYER, J. W, TIMMIS, A. D (1997). Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary?. Heart 78: 525-526 [Full text]